Conformationally biased P3 amide replacements of β-secretase inhibitors
- 1 February 2006
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 16 (3) , 641-644
- https://doi.org/10.1016/j.bmcl.2005.10.032
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Biochemical and cell-based assays for characterization of BACE-1 inhibitorsAnalytical Biochemistry, 2005
- Structure-Based Design of Potent and Selective Cell-Permeable Inhibitors of Human β-Secretase (BACE-1)Journal of Medicinal Chemistry, 2004
- Trans-Hydrometalation of Alkynes by a Combination of InCl3 and DIBAL-H: One-Pot Access to Functionalized (Z)-AlkenesOrganic Letters, 2002
- Substrate and Inhibitor Profile of BACE (β-Secretase) and Comparison with Other Mammalian Aspartic ProteasesPublished by Elsevier ,2002
- Secretase Targets for Alzheimer's Disease: Identification and Therapeutic PotentialJournal of Medicinal Chemistry, 2001
- The β-Secretase, BACE: A Prime Drug Target for Alzheimer's DiseaseJournal of Molecular Neuroscience, 2001
- Structure of the Protease Domain of Memapsin 2 (β-Secretase) Complexed with InhibitorScience, 2000
- P-Glycoprotein, a gatekeeper in the blood–brain barrierAdvanced Drug Delivery Reviews, 1999
- Synthetic methods and reactions. 181. Iodination of deactivated aromatics with N-iodosuccinimide in trifluoromethanesulfonic acid (NIS-CF3SO3H) via in situ generated superelectrophilic iodine(I) trifluoromethanesulfonateThe Journal of Organic Chemistry, 1993
- Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid proteinBiochemical and Biophysical Research Communications, 1984